SDC1 and Miyoshi myopathy: In our previous work, we demonstrated the clinical feasibility of analysing circulating MPs in MM, whereby the number of CD138+ circulating MPs was elevated in MM patients across all stages of disease and corresponds to plasma-cell burden and treatment response in individual patients23.